Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Spotlight Article

Analyzing key ATMP talking points through IP and regulatory lenses

2020 vision - Tools and Technologies of Tomorrow

Beatriz San Martin & Jackie Mulryne

Beatriz San Martin is an intellectual property specialist focusing her practice on the life sciences sector and emerging/disruptive technologies. She has significant experience handling cases before the UK Courts and the Court of Justice of the European Union, including high-profile European litigation. Beatriz was formerly a scientist with a Wellcome Trust PhD and a postdoctoral from the University of Cambridge specializing in genetics, cellular, and molecular biology. She is a member of the UK BioIndustry Association Cell and Gene Therapy Advisory Committee and Engineering Biology Advisory Committee.

Jackie Mulryne is a Partner at Arnold & Porter, focusing on regulatory and contentious matters for life sciences companies. She has advised a range of clients on the development and launch of innovative products, and assisted with navigating the regulatory landscape for novel cell and gene therapy products.

DOI: 10.18609/cgti.2019.174
Citation: Cell & Gene Therapy Insights 2019; 5(12), 1675–1690.
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog